Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.97 USD | -23.47% |
|
+0.55% | -1.48% |
Sales 2024 * | 60.47B 5,039B | Sales 2025 * | 62.71B 5,226B | Capitalization | 159B 13,213B |
---|---|---|---|---|---|
Net income 2024 * | 7.28B 607B | Net income 2025 * | 10.81B 901B | EV / Sales 2024 * | 3.6 x |
Net Debt 2024 * | 59.14B 4,928B | Net Debt 2025 * | 54.22B 4,519B | EV / Sales 2025 * | 3.39 x |
P/E ratio 2024 * |
20.6
x | P/E ratio 2025 * |
14.1
x | Employees | - |
Yield 2024 * |
5.97% | Yield 2025 * |
6.09% | Free-Float | 59.05% |
Latest transcript on Pfizer Inc.
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/93/01 |
David Denton
DFI | Director of Finance/CFO | 59 | 02/22/02 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 01/20/01 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23/17/23 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27/13/27 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
+0.20% | 120B |